Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B.

ClinicalTrials.gov ID: NCT01467427

Public ClinicalTrials.gov record NCT01467427. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 4:53 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is conducted in Asia, Europe and North America. The aim of the trial is to evaluate safety, efficacy and pharmacokinetics (the exposure of the trial drug in the body) of NNC-0156-0000-0009 (nonacog beta pegol, N9-GP) in previously treated children with Haemophilia B.

Study identification

NCT ID
NCT01467427
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
25 participants

Conditions and interventions

Eligibility (public fields only)

Age range
0 Years to 12 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 16, 2012 (Actual)
Primary completion
Nov 17, 2023 (Actual)
Completion
Nov 17, 2023 (Actual)
Last update posted
Dec 23, 2025

2012 – 2023

United States locations

U.S. sites
26
U.S. states
19
U.S. cities
25
Facility City State ZIP Site status
Children's Hospital Los Angeles - Endocrinology Los Angeles California 90027 —
UC Davis Medical Center Sacramento California 95817 —
Colorado Hemophilia & Thrombosis Center Aurora Colorado 80045 —
Childrens National Medical Ctr Washington D.C. District of Columbia 20010-2978 —
University of Miami Hospital & Clinics Miami Florida 33136 —
Emory University_Atlanta_1 Atlanta Georgia 30322 —
Augusta University Augusta Georgia 30912 —
University Of Iowa Iowa City Iowa 52242 —
University Of Louisville_Louisville_0 Louisville Kentucky 40202 —
Johns Hopkins University_Baltimore_3 Baltimore Maryland 21205 —
Children's Hospital of Michigan Detroit Michigan 48201 —
Children's Hospitals And Clinics Of Minnesota Minneapolis Minnesota 55404 —
The Children's Mercy Hospital Kansas City Missouri 64108-4619 —
Univ of NE Med Center_Omaha Omaha Nebraska 68198 —
Rutgers-Robert Wood Johnson Medical School New Brunswick New Jersey 08901 —
Maimonides Medical Center Brooklyn New York 11220 —
Mount Sinai Medical Center New York New York 10029 —
Univ Hosp Cleveland Med Ctr Cleveland Ohio 44106 —
Nationwide Children's Hospital Columbus Ohio 43205 —
Dayton Children Hemostati Ctr Dayton Ohio 45404 —
Univ Oklahoma Sci Ctr OK City Oklahoma City Oklahoma 73104 —
Children's Hosptl Philadelphia Philadelphia Pennsylvania 19104 —
Vanderbilt Hemostasis Thrombosis Clinic Nashville Tennessee 37232 —
Children's Medical Center_Dallas Dallas Texas 75235 —
Texas Children's Hospital_Houston Houston Texas 77030 —
Univ TX Hlth Sci Ctr Houston Houston Texas 77030 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01467427, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 23, 2025 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01467427 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →